Variant report

Variant	nsv593239
Chromosome Location	chr4:1078596-1087265
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:123)
CpG islands
(count:61)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:123 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:1078942-1079100	HepG2	liver:	n/a	n/a
2	CBX3	chr4:1082524-1082950	K562	blood:	n/a	n/a
3	CBX3	chr4:1082608-1082822	K562	blood:	n/a	n/a
4	CEBPB	chr4:1086409-1086563	HepG2	liver:	n/a	chr4:1086463-1086474 chr4:1086465-1086476 chr4:1086465-1086476
5	CTCF	chr4:1086100-1086250	GM12870	blood:	n/a	n/a
6	CTCF	chr4:1086190-1086319	GM12891	blood:	n/a	n/a
7	CTCF	chr4:1086200-1086350	GM12873	blood:	n/a	n/a
8	CTCF	chr4:1086160-1086310	GM06990	blood:	n/a	n/a
9	CTCF	chr4:1086220-1086370	HCPEpiC	choroid plexus:	n/a	n/a
10	CTCF	chr4:1086200-1086350	SK-N-SH_RA	brain:	n/a	n/a
11	CTCF	chr4:1086192-1086283	Medullo	brain:	n/a	n/a
12	CTCF	chr4:1086189-1086305	MCF-7	breast:	n/a	n/a
13	CTCF	chr4:1086202-1086291	MCF-7	breast:	n/a	n/a
14	CTCF	chr4:1086140-1086290	HepG2	liver:	n/a	n/a
15	CTCF	chr4:1086220-1086370	GM12864	blood:	n/a	n/a
16	CTCF	chr4:1086120-1086270	GM12873	blood:	n/a	n/a
17	CTCF	chr4:1086300-1086450	A549	lung:	n/a	n/a
18	CTCF	chr4:1086052-1086380	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTCF	chr4:1086120-1086270	WERI-Rb-1	eye:	n/a	n/a
20	CTCF	chr4:1086129-1086346	K562	blood:	n/a	n/a
21	CTCF	chr4:1086192-1086353	GM12878	blood:	n/a	n/a
22	CTCF	chr4:1086140-1086290	HUVEC	blood vessel:	n/a	n/a
23	CTCF	chr4:1086140-1086290	AG04449	skin:	n/a	n/a
24	CTCF	chr4:1086100-1086250	AG04450	lung:	n/a	n/a
25	CTCF	chr4:1086180-1086330	GM12871	blood:	n/a	n/a
26	CTCF	chr4:1086160-1086310	GM12873	blood:	n/a	n/a
27	CTCF	chr4:1086120-1086270	HCPEpiC	choroid plexus:	n/a	n/a
28	CTCF	chr4:1086120-1086270	GM12868	blood:	n/a	n/a
29	CTCF	chr4:1086160-1086310	WERI-Rb-1	eye:	n/a	n/a
30	CTCF	chr4:1086117-1086358	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTCF	chr4:1086080-1086230	K562	blood:	n/a	n/a
32	CTCF	chr4:1086120-1086270	SK-N-SH_RA	brain:	n/a	n/a
33	CTCF	chr4:1086080-1086230	WI-38	lung:	n/a	n/a
34	CTCF	chr4:1086140-1086290	HCFaa	heart:	n/a	n/a
35	CTCF	chr4:1086153-1086324	A549	lung:	n/a	n/a
36	CTCF	chr4:1086173-1086347	GM12878	blood:	n/a	n/a
37	CTCF	chr4:1086340-1086490	HFF-Myc	foreskin:	n/a	n/a
38	CTCF	chr4:1086120-1086270	GM12875	blood:	n/a	n/a
39	CTCF	chr4:1086141-1086327	Gliobla	brain:	n/a	n/a
40	CTCF	chr4:1086174-1086285	SK-N-SH_RA	brain:	n/a	n/a
41	CTCF	chr4:1086090-1086334	K562	blood:	n/a	n/a
42	CTCF	chr4:1086180-1086330	HA-sp	spinal cord:	n/a	n/a
43	CTCF	chr4:1086226-1086287	GM20000	blood:	n/a	n/a
44	CTCF	chr4:1085995-1086375	K562	blood:	n/a	n/a
45	CTCF	chr4:1086140-1086290	GM12869	blood:	n/a	n/a
46	CTCF	chr4:1086140-1086290	HRPEpiC	eye:	n/a	n/a
47	CTCF	chr4:1086120-1086270	AG09309	skin:	n/a	n/a
48	CTCF	chr4:1086160-1086310	GM12872	blood:	n/a	n/a
49	CTCF	chr4:1086200-1086350	GM12864	blood:	n/a	n/a
50	CTCF	chr4:1086100-1086250	MCF-7	breast:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:1086637-1086687	HepG2	liver:	n/a
2	chr4:1086637-1086687	HRPEpiC	eye:	n/a
3	chr4:1086637-1086687	Hepatocyte	liver:	n/a
4	chr4:1086637-1086687	ovcar-3	ovarian:	n/a
5	chr4:1086637-1086687	HNPCEpiC	eye:	n/a
6	chr4:1086637-1086687	GM06990	blood:	n/a
7	chr4:1086637-1086687	NB4	blood:	n/a
8	chr4:1086637-1086687	T-47D	breast:	n/a
9	chr4:1086637-1086687	NH-A	brain:	n/a
10	chr4:1086637-1086687	SK-N-MC	brain:	n/a
11	chr4:1086637-1086687	HL-60	blood:	n/a
12	chr4:1086637-1086687	GM12891	blood:	n/a
13	chr4:1086637-1086687	PFSK-1	brain:	n/a
14	chr4:1086637-1086687	HPAEpiC	pulmonary alveolar:	n/a
15	chr4:1086637-1086687	HCM	heart:	n/a
16	chr4:1086637-1086687	AG04450	lung:	fetal
17	chr4:1086637-1086687	HIPEpiC	eye:	n/a
18	chr4:1086637-1086687	HAEpiC	amniotic membrane:	n/a
19	chr4:1086637-1086687	ECC-1	luminal epithelium:	n/a
20	chr4:1086637-1086687	K562	blood:	n/a
21	chr4:1086637-1086687	AG09319	gingival:	n/a
22	chr4:1086637-1086687	AG04449	skin:	fetal
23	chr4:1086637-1086687	CMK	blood:	n/a
24	chr4:1086637-1086687	A549	lung:	n/a
25	chr4:1086637-1086687	HCF	heart:	n/a
26	chr4:1086637-1086687	ProgFib	skin:	n/a
27	chr4:1086637-1086687	HEEpiC	esophagus:	n/a
28	chr4:1086637-1086687	AG10803	skin:	n/a
29	chr4:1086637-1086687	Jurkat	blood:	n/a
30	chr4:1086637-1086687	NHDF-neo	bronchial:	n/a
31	chr4:1086637-1086687	Caco-2	colon:	n/a
32	chr4:1086637-1086687	SK-N-SH	brain:	n/a
33	chr4:1086637-1086687	PrEC	prostate:	n/a
34	chr4:1086637-1086687	SKMC	muscle:	n/a
35	chr4:1086637-1086687	RPTEC	kidney:	n/a
36	chr4:1086637-1086687	GM12878	blood:	n/a
37	chr4:1086637-1086687	H1-hESC	embryonic stem cell:	embryo
38	chr4:1086637-1086687	HEK293	kidney:	embryo
39	chr4:1086637-1086687	U87	brain:	n/a
40	chr4:1086637-1086687	HUVEC	blood vessel:	n/a
41	chr4:1086637-1086687	HRCEpiC	kidney:	n/a
42	chr4:1086637-1086687	AG09309	skin:	n/a
43	chr4:1086637-1086687	SK-N-SH_RA	brain:	n/a
44	chr4:1086637-1086687	NHBE	bronchial:	n/a
45	chr4:1086637-1086687	LNCaP	prostate:	n/a
46	chr4:1086637-1086687	HCT-116	colon:	n/a
47	chr4:1086637-1086687	HMEC	breast:	n/a
48	chr4:1086637-1086687	BJ	skin:	n/a
49	chr4:1086637-1086687	MCF-7	breast:	n/a
50	chr4:1086637-1086687	MCF10A-Er-Src	breast:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:1074111..1076189-chr4:1085996..1088070,2	K562	blood:
2	chr4:1078292..1079927-chr4:1283722..1285747,2	MCF-7	breast:
3	chr4:1032616..1034149-chr4:1078104..1080094,2	K562	blood:
4	chr4:1058468..1061069-chr4:1080892..1083707,2	K562	blood:
5	chr4:1076013..1078004-chr4:1078598..1081280,2	K562	blood:
6	chr4:1086221..1088731-chr4:1090765..1092594,2	MCF-7	breast:
7	chr4:1085294..1087604-chr4:1093899..1095690,2	K562	blood:

No data

Variant related genes	Relation type
RNF212	TF binding region
RNF212	CpG island
ENSG00000178222	chromatin interactions
ENSG00000251639	chromatin interactions

Extended variants
information (count: 371 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:371 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17164229	chr4:1078596-1078597	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs532900941	chr4:1078739-1078740	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
3	rs115764266	chr4:1078748-1078749	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs569713009	chr4:1078767-1078768	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
5	rs116148541	chr4:1078777-1078778	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs539066682	chr4:1078815-1078816	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs550529227	chr4:1078834-1078835	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs534853284	chr4:1078857-1078858	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs568632293	chr4:1078884-1078885	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs535689175	chr4:1078927-1078928	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
11	rs554190520	chr4:1078931-1078932	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs557496720	chr4:1078939-1078940	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
13	rs76115034	chr4:1078955-1078956	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs374309005	chr4:1078970-1078971	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs539972433	chr4:1079038-1079039	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs557710508	chr4:1079083-1079084	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs576065067	chr4:1079090-1079091	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs536913810	chr4:1079091-1079092	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs555263892	chr4:1079103-1079104	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs573735211	chr4:1079189-1079190	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs540878672	chr4:1079276-1079277	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs367842216	chr4:1079298-1079299	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs140928446	chr4:1079324-1079325	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs577660733	chr4:1079342-1079343	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs545117149	chr4:1079346-1079347	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs563257008	chr4:1079356-1079357	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs530533480	chr4:1079378-1079379	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs550464170	chr4:1079420-1079421	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs562370189	chr4:1079445-1079446	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs370672337	chr4:1079475-1079476	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs183417554	chr4:1079513-1079514	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs186026441	chr4:1079517-1079518	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs566293504	chr4:1079551-1079552	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs150384251	chr4:1079561-1079562	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs368058443	chr4:1079565-1079566	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs569687395	chr4:1079568-1079569	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs537050829	chr4:1079622-1079623	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs145079835	chr4:1079623-1079624	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs372968790	chr4:1079633-1079634	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs573845600	chr4:1079634-1079635	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs369580247	chr4:1079640-1079641	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs534964140	chr4:1079645-1079646	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs190735018	chr4:1079651-1079652	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs201086172	chr4:1079655-1079656	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs545089923	chr4:1079662-1079663	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs374307132	chr4:1079665-1079666	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs540539692	chr4:1079667-1079668	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs377718039	chr4:1079669-1079670	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs200680799	chr4:1079676-1079677	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs371423387	chr4:1079677-1079678	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Wolf-Hirschhorn syndrome	21549014	CNVD
Breast cancer	21806811	CNVD
Wolf-Hirschhorn syndrome	22283845	CNVD
Wolf-Hirschhorn syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Wolf-Hirschhorn syndrome	22470819	CNVD
Wolf-Hirschhorn syndrome	18541967	CNVD
sporadic birth defects	19047251	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Retinitis pigmentosa	18421352	CNVD
Wolf-Hirschhorn syndrome	19259404	CNVD
Bladder cancer	19242612	CNVD
Breast cancer	19242612	CNVD
Congenital anomalies of the kidney and urinary tract	19242612	CNVD
abnormal development	18461090	CNVD
Olfactory neuroblastoma	18408657	CNVD
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17142309	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	22297974	CNVD
Breast cancer	20932292	CNVD
Cancer	20164919	CNVD
Type 2 diabetes	21754918	CNVD
Breast cancer	22522925	CNVD
Glioma	20126413	CNVD

Chromatin state (count:49 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:1076800-1078600	Weak transcription	Adipose Nuclei	Adipose
2	chr4:1076800-1078800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr4:1076800-1080000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr4:1076800-1082400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr4:1077600-1078600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr4:1077600-1078600	Weak transcription	Pancreas	Pancrea
7	chr4:1078600-1078800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr4:1078600-1078800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
9	chr4:1078600-1079000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
10	chr4:1078600-1080200	Enhancers	Adipose Nuclei	Adipose
11	chr4:1078600-1080200	Enhancers	Pancreas	Pancrea
12	chr4:1078800-1079000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr4:1078800-1079000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
14	chr4:1078800-1079000	Bivalent Enhancer	NHDF-Ad	bronchial
15	chr4:1078800-1079200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr4:1079000-1079400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
17	chr4:1079000-1080200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr4:1079400-1080400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
19	chr4:1079800-1080000	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr4:1080000-1080200	Enhancers	Primary T killer memory cells from peripheral blood	blood
21	chr4:1080000-1080200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr4:1080000-1080200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
23	chr4:1080000-1080400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
24	chr4:1080000-1080400	Enhancers	Spleen	Spleen
25	chr4:1080200-1086000	Weak transcription	Pancreas	Pancrea
26	chr4:1080400-1081200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
27	chr4:1081200-1082600	ZNF genes & repeats	Primary Natural Killer cells fromperipheralblood	blood
28	chr4:1083200-1085200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr4:1083800-1084800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr4:1084200-1093400	Weak transcription	Ovary	ovary
31	chr4:1084800-1085000	Enhancers	Spleen	Spleen
32	chr4:1084800-1086200	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
33	chr4:1085000-1088400	Weak transcription	Spleen	Spleen
34	chr4:1085600-1085800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr4:1085600-1085800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
36	chr4:1085600-1086000	Enhancers	Lung	lung
37	chr4:1085800-1086600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr4:1085800-1088200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
39	chr4:1086000-1086200	Enhancers	Gastric	stomach
40	chr4:1086000-1086600	Enhancers	Fetal Muscle Leg	muscle
41	chr4:1086000-1087000	Enhancers	Liver	Liver
42	chr4:1086000-1087600	Strong transcription	Pancreas	Pancrea
43	chr4:1086000-1098400	Weak transcription	Lung	lung
44	chr4:1086200-1086400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
45	chr4:1086200-1091400	Weak transcription	Gastric	stomach
46	chr4:1086200-1098600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr4:1086600-1087000	Weak transcription	Fetal Muscle Leg	muscle
48	chr4:1086600-1087800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr4:1087000-1088600	Enhancers	Fetal Muscle Leg	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links